Term: galiximab

Pronunciation: (guh-LIK-sih-mab)

Description:

A substance being studied in the treatment of follicular non-Hodgkin lymphoma. It binds to the protein CD80, which is found on certain normal white blood cells and on white blood cells that are cancer. It is a type of monoclonal antibody.